The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

Trial Profile

The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Mar 2018

At a glance

  • Drugs Enterovirus A vaccine (Primary)
  • Indications Coxsackievirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Feb 2018 The primary endpoint has been amended from Adverse events to Efficacy of the vaccine and hence the trial focus has also changed from AE to TU
    • 27 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
    • 27 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top